Table 1 Patients’ baseline characteristics, TRUS findings and MRI findings

Age, year (IQR)

71 (65–77)

PSA, ng/mL (IQR)

10.04 (6.38–18.00)

Suspicious DRE findings, n (%)

74 (26.52)

TRUS prostate volume, mL (IQR)

57.00 (41.00–82.30)

Men with prior biopsy, n (%)

89 (31.90)

Men without biopsy history, n(%)

190 (68.10)

Abnormal TRUS findings, n (%)

139 (49.82)

Urologists’ biopsy experience, year (IQR)

4 (4–5)

MRI suspicious lesions per patient, no. (IQR)

1 (1–1)

Total lesions, no

353

PIRADS v2 score, n (%)

 3

113 (32.01)

 4

169 (47.88)

 5

71 (20.11)

Location

 Peripheral zone, n (%)

232 (65.72)

 Transitional zone, n (%)

121 (34.28)